Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2020

Aug 20, 2020

34105_dirs_2020-08-20_4bf394b1-f0c5-40d7-a6d3-bbc5253b0032.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2020-08-19

Reporting Person: Robert W. Shaw (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-19 Common Stock; $.10 par value P 2500 $6.41 Acquired 56000 Direct